Skip to main content
. 2015 Aug 13;2(3):249–259. doi: 10.1007/s40801-015-0035-4

Table 1.

Characteristics of the final matched study population with incident PIM use and no PIM use

Characteristic Non-PIM PIM Total
Patients [N (%)] 17,848 (50.00) 17,848 (50.00) 35,696
Sex [N (%)]
 Female 11,030 (50.56) 10,785 (49.44) 21,815
 Male 6818 (49.12) 7063 (50.88) 13,881
Age [N (%)]
 65–69 years 3937 (49.80) 3969 (50.20) 7906
 70–74 years 5050 (49.75) 5100 (50.25) 10,150
 75–79 years 3857 (51.65) 3611 (48.35) 7468
 80–84 years 2752 (48.13 2966 (51.87) 5718
 85–89 years 1503 (51.86) 1395 (48.14) 2898
 90–94 years 531 (48.67) 560 (51.33) 1091
 95+ years 218 (46.88) 247 (53.12) 465
Charlson comorbidity index score [N (%)]
 0 9675 (50.65) 9428 (49.35) 19,103
 1 3580 (50.33) 3533 (49.67) 7113
 2 2051 (49.53) 2090 (50.47) 4141
 3 1113 (48.97) 1160 (51.03) 2273
 4 990 (47.55) 1092 (52.45) 2082
 5+ 439 (44.61) 545 (55.39) 984
Adverse drug event: hospitalization [N (%)] 127 (39.44) 195 (60.56) 322
 OR for hospitalization (95 % CI) Reference 1.54 (1.23–1.93)

CI confidence interval, OR odds ratio, PIM potentially inappropriate medication